ATHEROSCLEROSIS / CLINICAL RESEARCH
Deep learning-based multimodal risk stratification for atherosclerosis management
More details
Hide details
1
Vasculocardiology Department, Yongkang First People’s Hospital Affiliated to Hangzhou Medical College, Yongkang, China
2
Pharmacy Department, Yongkang First People’s Hospital Affiliated to Hangzhou Medical College, Yongkang, China
Submission date: 2025-06-05
Final revision date: 2025-07-09
Acceptance date: 2025-07-14
Online publication date: 2025-08-23
Corresponding author
Zhenzhong Zhu
Vasculocardiology Department
Yongkang First People’s
Hospital Affiliated to
Hangzhou Medical College
599 Jinshan West Road
Dongcheng Street
Yongkang 321300
Zhejiang, China
Phone: +86-0579-89279021
Yunxiang Wang
Vasculocardiology Department
Yongkang First People’s
Hospital Affiliated to
Hangzhou Medical College
599 Jinshan West Road
Dongcheng Street
Yongkang 321300
Zhejiang, China
Phone: +86-0579-89279021
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Atherosclerosis is a leading cause of cardiovascular events, requiring accurate risk stratification. Traditional methods rely on subjective imaging and clinical scores, limiting precision.
Material and methods:
We developed a deep learning (DL) model combining U-Net for lesion segmentation, ResNet for classification, and an attention mechanism to enhance detection of high-risk plaques. Multimodal data – including ultrasound, CTA, and clinical variables – underwent standard preprocessing. The dataset was split (8 : 1 : 1) and evaluated using 5-fold cross-validation.
Results:
The U-Net achieved a Dice coefficient of 0.88. The ResNet, integrated with clinical features, reached 92% classification accuracy and an AUC of 0.97. The attention mechanism improved vulnerable plaque detection by 10%. Grad-CAM visualizations showed 85% agreement with expert annotations. Processing time was reduced by 70% compared to traditional assessment methods. Multicenter validation confirmed strong generalizability.
Conclusions:
This study constructed a multimodal DL model that significantly enhances the clinical value of atherosclerosis risk stratification. The prediction accuracy increased to 92% with an AUC of 0.97, and the average processing time per case was reduced from 6.3 ±1.4 minutes to 1.9 ±0.4 minutes (a reduction of approximately 70%). The model demonstrated higher precision in both lesion segmentation and high-risk plaque identification, providing clinicians with a rapid and reliable decision-support tool that is expected to further optimize individualized intervention strategies and improve patient prognosis.
REFERENCES (28)
1.
Savo MT, De Amicis M, Cozac DA, et al. Comparative prognostic value of coronary calcium score and perivascular fat attenuation index in coronary artery disease. J Clin Med 2024; 13: 5205.
2.
Monlezun DJ, MacKay K. Artificial intelligence and health inequities in dietary interventions on atherosclerosis: a narrative review. Nutrients 2024; 16: 2601.
3.
Koloi A, Loukas VS, Hourican C, et al. Predicting early-stage coronary artery disease using machine learning and routine clinical biomarkers improved by augmented virtual data. Eur Heart J Digital Health 2024; 5: 542-50.
4.
Singh M, Kumar A, Khanna NN, et al. Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review. eClinicalMedicine 2024; 73: 102660.
5.
Oikonomou EK, Khera R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovasc Diabetol 2023; 22: 259.
6.
Saba L, Maindarkar M, Khanna NN, et al. A pharmaceutical paradigm for cardiovascular composite risk assessment using novel radiogenomics risk predictors in precision explainable artificial intelligence framework: clinical trial tool. Front Biosci 2023; 28: 248.
7.
Banchhor SK, Londhe ND, Araki T, et al. Calcium detection, its quantification, and grayscale morphology-based risk stratification using machine learning in multimodality big data coronary and carotid scans: a review. Computers Biol Med 2018; 101: 184-98.
8.
He K, Zhang R, Liang M, et al. The application of deep learning in early enamel demineralization detection. PeerJ 2025; 13: e18593.
9.
Lakshmi K, Amaran S, Subbulakshmi G, Padmini S, Joshi GP, Cho W. Explainable artificial intelligence with UNet based segmentation and Bayesian machine learning for classification of brain tumors using MRI images. Sci Rep 2025; 15: 690.
10.
Chen H, Lai H, Chi H, et al. Multi-modal transcriptomics: integrating machine learning and convolutional neural networks to identify immune biomarkers in atherosclerosis. Front Cardiovasc Med 2024; 11: 1397407.
11.
Jain PK, Dubey A, Saba L, et al. Attention-based UNet Deep Learning Model for plaque segmentation in carotid ultrasound for stroke risk stratification: an artificial intelligence paradigm. J Cardiovasc Dev Dis 2022; 9: 326.
12.
Lee YC, Cha J, Shim I, et al. Multimodal deep learning of fundus abnormalities and traditional risk factors for cardiovascular risk prediction. npj Digit Med 2023; 6: 14.
13.
Barriada RG, Masip D. An overview of deep-learning-based methods for cardiovascular risk assessment with retinal images. Diagnostics 2022; 13: 68.
14.
Tokodi M, Shah R, Jamthikar A, et al. Deep learning model of diastolic dysfunction risk stratifies the progression of early-stage aortic stenosis. JACC Cardiovasc Imaging 2025; 18: 150-65.
15.
Huang Z, Lam S, Lin Z, et al. Predicting major adverse cardiac events using radiomics nomogram of pericoronary adipose tissue based on CCTA: a multi‐center study. Med Phys 2024; 51: 8348-61.
16.
Omarov M, Zhang L, Jorshery SD, et al. Deep learning-based detection of carotid plaques informs cardiovascular risk prediction and reveals genetic drivers of atherosclerosis. medRxiv 2025; 2024.10.1101/2024.10.24315675.
17.
Jaltotage B, Lu J, Dwivedi G. Use of artificial intelligence including multimodal systems to improve the management of cardiovascular disease. Can J Cardiol 2024; 40: 1804-12.
18.
Kampaktsis PN, Emfietzoglou M, Al Shehhi A, et al. Artificial intelligence in atherosclerotic disease: applications and trends. Front Cardiovasc Med 2023; 9: 949454.
19.
van Assen M, Tariq A, Razavi AC, Yang C, Banerjee I, De Cecco CN. Fusion modeling: combining clinical and imaging data to advance cardiac care. Circ Cardiovasc Imaging 2023; 16: e014533.
20.
Gallone G, Bellettini M, Gatti M, et al. Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions. JACC Cardiovasc Imaging 2023; 16: 1584-604.
21.
Sarraju A, Nissen SE. Atherosclerotic plaque stabilization and regression: a review of clinical evidence. Nat Rev Cardiol 2024; 21: 487-97.
22.
Lin A, Kolossváry M, Motwani M, et al. Artificial intelligence in cardiovascular imaging for risk stratification in coronary artery disease. Radiol Cardiothorac Imaging 2021; 3: e200512.
23.
Bhagawati M, Paul S, Mantella L, et al. Cardiovascular disease risk stratification using hybrid deep learning paradigm: first of its kind on Canadian Trial Data. Diagnostics 2024; 14: 1894.
24.
Amal S, Safarnejad L, Omiye JA, Ghanzouri I, Cabot JH, Ross EG. Use of multi-modal data and machine learning to improve cardiovascular disease care. Front Cardiovasc Med 2022; 9: 840262.
25.
Prajapati NK, Patel A, Mewada H. Automated diagnosis of atherosclerosis using multi-layer ensemble models and bio-inspired optimization in intravascular ultrasound imaging. Med Biol Eng Comput 2024; 63: 213-27.
26.
Quan X, Ou X, Gao L, Yin W, Hou G, Zhang H. SCINet: a segmentation and classification interaction CNN method for arteriosclerotic retinopathy grading. Interdiscip Sci Comput Life Sci 2024; 16: 926-35.
27.
Lewandowski Ł, Czapla M, Uchmanowicz I, et al. Machine learning and clinical predictors of mortality in cardiac arrest patients: a comprehensive analysis. Med Sci Monit 2024; 30: e944408.
28.
Nazir S, Dickson DM, Akram MU. Survey of explainable artificial intelligence techniques for biomedical imaging with deep neural networks. Comp Biol Med 2023; 156: 106668.